GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.5749
-0.0050 (-0.86%)
At close: Oct 6, 2025, 4:00 PM EDT
0.5719
-0.0030 (-0.52%)
After-hours: Oct 6, 2025, 7:38 PM EDT
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $14.58 million as of October 6, 2025. Its market cap has decreased by -35.61% in one year.
Market Cap
14.58M
Enterprise Value
11.49M
1-Year Change
-35.61%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since May 13, 2019, GeoVax Labs's market cap has increased from $1.04M to $14.58M, an increase of 1,296.51%. That is a compound annual growth rate of 50.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 14.58M | -37.45% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.01% |
| Dec 31, 2020 | 12.03M | 6,734.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |